About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Wbp2tm2a(EUCOMM)Wtsi
targeted mutation 2a, Wellcome Trust Sanger Institute
MGI:4847848
Summary 3 genotypes


Genotype
MGI:5782224
hm1
Allelic
Composition
Wbp2tm2a(EUCOMM)Wtsi/Wbp2tm2a(EUCOMM)Wtsi
Genetic
Background
C57BL/6N-Wbp2tm2a(EUCOMM)Wtsi/Cnrm
Cell Lines EPD0037_2_G04
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Wbp2tm2a(EUCOMM)Wtsi mutation (3 available); any Wbp2 mutation (33 available)
Data Sources
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
IMPC - HAR

growth/size/body

hematopoietic system

immune system




Genotype
MGI:5781793
hm2
Allelic
Composition
Wbp2tm2a(EUCOMM)Wtsi/Wbp2tm2a(EUCOMM)Wtsi
Genetic
Background
C57BL/6N-Wbp2tm2a(EUCOMM)Wtsi/Wtsi
Cell Lines EPD0037_2_D06
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Wbp2tm2a(EUCOMM)Wtsi mutation (3 available); any Wbp2 mutation (33 available)
Data Sources
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
IMPC - WTSI
IMPC - WTSI

homeostasis/metabolism




Genotype
MGI:5817994
hm3
Allelic
Composition
Wbp2tm2a(EUCOMM)Wtsi/Wbp2tm2a(EUCOMM)Wtsi
Genetic
Background
involves: C57BL/6N * C57BL/6NTac
Cell Lines EPD0037_2_D06
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Wbp2tm2a(EUCOMM)Wtsi mutation (3 available); any Wbp2 mutation (33 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hearing/vestibular/ear
N
• mice exhibit grossly normal middle and inner ear structure with no overt degeneration of hair cells or spiral ganglion neurons up to 30 weeks of age
• single IHCs show normal mechanoelectrical transducer current and capacitance changes upon depolarisation, suggesting normal neurotransmitter release
• at P28, TEM analysis of the organ of Corti revealed swelling of afferent terminals below inner and outer hair cells
• at P14, afferent terminals below IHCs are slightly swollen in the 24-kHz cochlear region relative to those in wild-type controls
• at P28, severe swelling of afferent terminals is noted under all IHCs, esp. in the 24-kHz region, while some pre-synaptic ribbons do not appear as well aligned to the terminals
• at 4 weeks of age, IHC synapses show reduced expression of GluR2/3 (a marker for AMPA receptor subunits at post-synaptic densities) and poor overlap between pre-synaptic ribbons and post-synaptic densities, suggesting a post-synaptic defect
• TEM analysis showed an array of synaptic phenotypes in the 24-kHz region including: differentially shaped/sized ribbons, orphan post-synaptic densities and orphan ribbons, ribbons with attached synaptic membranes floating in the swollen afferent terminals, as well as close-to-normal looking synapses
• by 8 weeks of age, swollen and retracting terminals are observed, and swelling is more severe in the 24-kHz region compared to the 9-kHz region, consistent with high-frequency hearing loss
• however, the number of pre-synaptic ribbons per IHC is normal in the 8-, 18- and 24-kHz regions at both 4 and 8 weeks of age
• at P28, swelling of OHC afferent terminals is observed in the 24-kHz region
• at 4 weeks of age, averaged click-evoked ABR waveforms at 50-dB sensation level revealed a normal waveform shape but a reduced ABR amplitude
• ABR wave 1 amplitudes show a significant reduction and a longer latency relative to those in wild-type controls, suggesting reduced auditory nerve activity
• although ABR thresholds are normal at P14, mice exhibit increased ABR thresholds at frequencies of 24 kHz or higher by 4 weeks of age
• hearing loss is more evident at 14 and 28 weeks and spreads to lower frequencies by 44 weeks of age
• however, no endocochlear potential deficits are observed
• at 4 weeks of age, the summating potential is reduced and grows at a reduced rate as stimulus level increases
• however, latency is similar to that in wild-type controls
• at 4 weeks of age, mice show increased 2f1-f2 DPOAE thresholds for 24- and 30-kHz f2 tones
• by 21 weeks of age, 2f1-f2 DPOAE thresholds are increased for all test frequencies (6-30 kHz), esp. at 18-30 kHz, indicating OHC dysfunction
• mice exhibit progressive high-frequency hearing loss from as early as 4 weeks of age
• at 4 weeks of age, hearing loss is associated with reduced expression of Esr1, Esr2 and Pgr, decreased expression of GluR2/3 AMPA subunits, and increased transcription of Shank3 and Dlg4 (encoding Psd-95) in the cochlea as well as increased Psd95 protein levels in IHC synapses, thus linking hearing impairment to hormonal signaling

nervous system
• at P14, afferent terminals below IHCs are slightly swollen in the 24-kHz cochlear region relative to those in wild-type controls
• at P28, severe swelling of afferent terminals is noted under all IHCs, esp. in the 24-kHz region, while some pre-synaptic ribbons do not appear as well aligned to the terminals
• at 4 weeks of age, IHC synapses show reduced expression of GluR2/3 (a marker for AMPA receptor subunits at post-synaptic densities) and poor overlap between pre-synaptic ribbons and post-synaptic densities, suggesting a post-synaptic defect
• TEM analysis showed an array of synaptic phenotypes in the 24-kHz region including: differentially shaped/sized ribbons, orphan post-synaptic densities and orphan ribbons, ribbons with attached synaptic membranes floating in the swollen afferent terminals, as well as close-to-normal looking synapses
• by 8 weeks of age, swollen and retracting terminals are observed, and swelling is more severe in the 24-kHz region compared to the 9-kHz region, consistent with high-frequency hearing loss
• however, the number of pre-synaptic ribbons per IHC is normal in the 8-, 18- and 24-kHz regions at both 4 and 8 weeks of age
• at P28, swelling of OHC afferent terminals is observed in the 24-kHz region

homeostasis/metabolism
• females, but not males, show reduced circulating amylase levels





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory